Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy

Details for Australian Patent Application No. 2004247145 (hide)

Owner Rath, M.

Inventors Niedzwiecki, Aleksandra; Ivanov, Vadim; Rath, Matthias; Netke, Shrirang

Agent Shelston IP

Pub. Number AU-A-2004247145

PCT Pub. Number WO2004/110383

Priority 10/460,023 11.06.03 US

Filing date 11 June 2004

Wipo publication date 23 December 2004

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/110383 Priority application(s): WO2004/110383

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247146-HIV-1 envelope glycoproteins having unusual disulfide structure

2004247143-Osteoimplants and methods for their manufacture